Molecular characterization of homozygous hereditary factor I deficiency

Clinical and Experimental Immunology

Volumn 131, Issue 2, 2003, Pages 280-286

  Baracho, G V ^b   Nudelman, V ^b   Isaac, L ^a  

^a Hospital Universitario   (Brazil)

^b NONE

Author keywords

Complement system; Decay stop codon; Immunodeficiency factor I mRNA

Indexed keywords

GLYCOPROTEIN;

ALLELE; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT SYSTEM; COVALENT BOND; DNA SEQUENCE; FIBRINOGEN DEFECT; GENETIC DISORDER; HOMOZYGOSITY; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOP CODON;

EID: 0037318443     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02077.x     Document Type: Article

References (32)

1. Hebell T, Ahearn JM, Fearon DT. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 1991; 254:102-5.
2. Croix D, Ahearn J, Rosengard A, Han S, Kelsoe G, Ma M, Carroll MC. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med 1996; 183:1857-64.
3. Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996; 271:348-50.
4. Molina H, Holers VM, Li B, Fang Y-F, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 1996; 93:3357-61.
5. Vyse TJ, Späth PJ, Davies KA, Morley BJ, Philippe P, Athanassiou P, Giles CM, Walport MJ. Hereditary complement factor I deficiency. Q J Med 1994; 87:385-402.
6. Goldberger G, Arnaout MA, Aden D, Kay R, Ritz M, Colten HR. Biosynthesis and postsynthesis processing of human C3b/C4b inactivator (factor I) in three hepatoma cell lines. J Biol Chem 1984; 259:6492-7.
7. Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by the human peripheral blood monocytes. J Exp Med 1980; 151:501-16.
8. Julen N, Dauchel H, Lemercier CD, Sim RB, Fontaine M, Ripoche J. In vitro biosynthesis of complement factor I by human endothelial cells. Eur J Immunol 1992; 22:213-7.
9. Vetvicka V, Reed W, Hoover ML, Ross GD. Complement factor H and I synthesized by B cells lines function to generate a growth factor activity from C3. J Immunol 1993; 150:4052-60.
10. Vyse TJ, Morley BJ, Bartók I, Theodoridis EL, Davies KA, Webster ADB, Walport MJ. The molecular basis of hereditary complement factor I deficiency. J Clin Invest 1996; 97:925-33.
11. Vyse TJ, Bates GP, Walport MJ, Morley BJ. The organization of the human complement factor I gene (IF): a member of the serine protease gene family. Genomics 1994; 24:90-8.
12. Shiang R, Murray JC, Morton CC, Buetow KH, Wasmuth JJ, Olney AH, Sanger WG, Goldberger G. Mapping of the human complement factor I gene to 4q25. Genomics 1989; 4:82-6.
13. Paramaswara B, Minta JO. An initiator element and a proximal cis-acting sequence are essential for transcriptional activation of the complement factor I (CFI) gene. Gene 1999; 237:71-80.
14. Minta JO, Fung M, Paramaswara B. Transcriptional and posttranscriptional regulation of complement factor I (CFI) gene expression in Hep-G2 cells by interleukin-6. Biochim Biophys Acta 1998; 1442:286-95.
15. Minta JO, Fung M. Transcriptional modulation of the human complement factor I gene in Hep-G2 cells by protein kinase C activation. Mol Cell Bioch 1999; 201:111-23.
16. Leitão MF, Vilela MMS, Rutz R, Grumach AS, Condino-Neto A, Kirschfink M. Complement factor I deficiency in a family with recurrent infections. Immunopharmacol 1997; 38:207-13.
17. Naked GM, Pereira MCF, Ferreira de Paula P, Vinet AMR, Inostroza JS, Isaac L. Deficiency of human complement factor I associated with lowered factor H. Clin Immunol 2000; 96:1662-77.
18. Amadei N, Baracho GV, Nudelman V, Bastos W, Florido MPC, Isaac L. Inherited complete factor I deficiency and systemic lupus erythematosus in a family with low levels of factor H. Scand J Immunol 2001; 53:615-21.
19. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor: Cold Spring. Harbor Laboratory Press, 1989.
20. de Bruijin MHL, Fey G. Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci USA 1985; 82:707-12.
21. Ripoche J, Day AJ, Harris TJ, Sim RB. The complete amino acid sequence of human complement factor H. Biochem J 1988; 249:593-602.
22. Catterall CF, Lyons A, Sim RB, Day AJ, Harris TJR. Characterization of the primary amino acid sequence of human complement control protein factor I from an analysis of cDNA. Biochem J 1987; 242:849-56. Submission to GenBank: http://wwwncbinlmnihgov/blast.
23. Morley BJ, Bartók I, Späth PJ, Vyse TJ, Schneider PM, Walport MJ. Molecular basis of hereditary factor I deficiency. Mol Immunol 1998; 35:344.
24. Antonarakis SE and the Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Hum Mut 1998; 11:1-3.
25. Maquat LE. When cells stop making sense. Effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1995; 1:453-65.
26. Maquat LE. Defects in RNA splicing and the consequence of shortened translational reading frames. Am J Hum General 1996; 59:279-86.
27. Lykke-Andersen J, Shu M-D, Steitz JA. Human Upf proteins target a mRNA for nonsense-mediated decay when bound downstream of a termination codon. Cell 2000; 103:1121-31.
28. Kim VN, Kataoka N, Dreyfuss G. Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex. Science 2001; 293:1832-6.
29. Hall GW, Thein S. Nonsense codon mutations in the terminal exon of the beta-globin gene are not associated with a reduction in beta-mRNA accumulation, a mechanism for the phenotype of dominant beta-thalassemia. Blood 1994; 83:2031-7.
30. Pitts SA, Kullar HS, Stankovic T et al. hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay. Hum Mol Genet 2001; 10 (11):1155-62.
31. Reis ES, Baracho GV, Lima AS, Farah CS, Isaac L. Homozygous hereditary C3 deficiency due to a stop codon. J Clin Immunol 2002; 22:321-30.
32. Ulbrich AG, Florido MPC, Nudelman V, Reis ES, Baracho GV, Isaac L. Hereditary human complement C3 deficiency owing to reduced levels of C3 mRNA. Scand J Immunol 2001; 53:622-6.